The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Structure of glutamate carboxypeptidase II, a drug target in neuronal damage and prostate cancer
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The CCP4 suite: programs for protein crystallography
Collaborative Computational Project, N. 4. (1994) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444994003112 · Cited by 17,270
Refinement of Macromolecular Structures by the Maximum-Likelihood Method
Murshudov, G. N., Vagin, A. A., & Dodson, E. J. (1997) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444996012255 · Cited by 14,742
Benveniste, H., Drejer, J., Schousboe, A., & Diemer, N. H. (1984) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1984.tb05396.x · Cited by 2,859
XtalView/Xfit—A Versatile Program for Manipulating Atomic Coordinates and Electron Density
McRee, D. E. (1999) · Journal of Structural Biology · doi:10.1006/jsbi.1999.4094 · Cited by 2,094
Tumor target prostate specific membrane antigen (PSMA) and its regulation in prostate cancer
Ghosh, A., & Heston, W. D. W. (2004) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10661 · Cited by 878
MEROPS: the peptidase database
Rawlings, N. D., & Barrett, A. J. (1999) · Nucleic Acids Research · doi:10.1093/nar/27.1.325 · Cited by 793
The Role of Excitotoxicity in Neurodegenerative Disease
Doble, A. (1999) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(98)00042-4 · Cited by 723
Constitutive and antibody-induced internalization of prostate-specific membrane antigen.
Liu, H., Rajasekaran, A. K., Moy, P., Xia, Y., Kim, S., Navarro, V., Rahmati, R., & Bander, N. H. (1998) · PubMed · Cited by 458
ALIGN: a program to superimpose protein coordinates, accounting for insertions and deletions
Cohen, G. E. (1997) · Journal of Applied Crystallography · doi:10.1107/s0021889897006729 · Cited by 397
Prostate-specific membrane antigen: a novel folate hydrolase in human prostatic carcinoma cells.
Pinto, J. T., Suffoletto, B. P., Berzin, T. M., Qiao, C. H., Lin, S., Tong, W. P., May, F., Mukherjee, B., & Heston, W. D. W. (1996) · PubMed · Cited by 389
MEROPS: the peptidase database
Rawlings, N. D. (2004) · Nucleic Acids Research · doi:10.1093/nar/gkh071 · Cited by 376
Carter, R. E., Feldman, A. R., & Coyle, J. T. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.2.749 · Cited by 372
Crystal structure of the hereditary haemochromatosis protein HFE complexed with transferrin receptor
Bennett, M. J., Lebrón, J. A., & Bjorkman, P. J. (2000) · Nature · doi:10.1038/47417 · Cited by 337
Crystal Structure of the Ectodomain of Human Transferrin Receptor
Lawrence, C. M., Ray, S., Babyonyshev, M., Galluser, R., Borhani, D. W., & Harrison, S. C. (1999) · Science · doi:10.1126/science.286.5440.779 · Cited by 315 · cited 2×
“However, there is a pronounced similarity of the GCPII structure to the structure of the transferrin receptor (TfR) (Lawrence et al, 1999; Bennett et al, 2000), in spite of the latter not having any enzymatic activity (see Supplementary Table 3 for details).”
BackgroundTherapeutic potential of excitatory amino acid antagonists: channel blockers and 2,3-benzodiazepines
Rogawski, M. A. (1993) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(93)90005-5 · Cited by 313
Utility of homology models in the drug discovery process
Hillisch, A., Pineda, L. F., & Hilgenfeld, R. (2004) · Drug Discovery Today · doi:10.1016/s1359-6446(04)03196-4 · Cited by 310
Self-citationRapoport, I. (1998) · The EMBO Journal · doi:10.1093/emboj/17.8.2148 · Cited by 307
Robinson, M. B., Blakely, R. D., Couto, R., & Coyle, J. T. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)47823-4 · Cited by 306
Engel, M., Hoffmann, T., Wagner, L., Wermann, M., Heiser, U., Kiefersauer, R., Huber, R., Bode, W., Demuth, H.-U., & Brandstetter, H. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0230620100 · Cited by 305
Glutamate, excitotoxicity and amyotrophic lateral sclerosis
Shaw, P. J., & Ince, P. G. (1997) · Journal of Neurology · doi:10.1007/bf03160574 · Cited by 300
N‐Acetylaspartylglutamate Selectively Activates mGluR3 Receptors in Transfected Cells
Wroblewska, B., Wroblewski, J. T., Pshenichkin, S., Surin, A., Sullivan, S. E., & Neale, J. H. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69010174.x · Cited by 298
Crystal structure of prostate-specific membrane antigen, a tumor marker and peptidase
Davis, M. I., Bennett, M. J., Thomas, L. M., & Bjorkman, P. J. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0502101102 · Cited by 296
Selective inhibition of NAALADase, which converts NAAG to glutamate, reduces ischemic brain injury
Slusher, B. S., Vornov, J. J., Thomas, A. G., Hurn, P. D., Harukuni, I., Bhardwaj, A., Traystman, R. J., Robinson, M. B., Britton, P., Lu, X.-C. M., et al. (1999) · Nature Medicine · doi:10.1038/70971 · Cited by 295
Self-citationAutomated structure solution, density modification and model building
Terwilliger, T. C. (2002) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444902016438 · Cited by 284
Butcher, S. P., Bullock, R., Graham, D. I., & McCulloch, J. (1990) · Stroke · doi:10.1161/01.str.21.12.1727 · Cited by 271
Jackson, P. F., Cole, D. C., Slusher, B. S., Stetz, S. L., Ross, L. E., Donzanti, B. A., & Trainor, D. A. (1996) · Journal of Medicinal Chemistry · doi:10.1021/jm950801q · Cited by 256
Self-citationChevrier, B., Schalk, C., D'Orchymont, H., Rondeau, J. M., Moras, D., & Tarnus, C. (1994) · Structure · doi:10.1016/s0969-2126(00)00030-7 · Cited by 244
The homodimer of prostate-specific membrane antigen is a functional target for cancer therapy
Schülke, N., Varlamova, O. A., Donovan, G. P., Ma, D., Gardner, J. P., Morrissey, D. M., Arrigale, R. R., Zhan, C., Chodera, A. J., Surowitz, K. G., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1735443100 · Cited by 232
Excitatory amino acid synaptic mechanisms and neurological function
Fagg, G. E., Foster, A. C., & Ganong, A. H. (1986) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(86)90386-x · Cited by 229
Rajasekaran, S. A., Anilkumar, G., Oshima, E., Bowie, J. U., Liu, H., Heston, W., Bander, N. H., & Rajasekaran, A. K. (2003) · Molecular Biology of the Cell · doi:10.1091/mbc.e02-11-0731 · Cited by 226 · cited 1×
“…several features characteristic of receptor proteins, such as sequence signatures for endocytic internalization (Liu et al, 1998; Rapoport et al, 1998; Rajasekaran et al, 2003), or binding to filamin A, resulting in GCPII localization to the recycling endosomal compartment (Anilkumar et al, 2003).”
BackgroundARP/wARP's model-building algorithms. I. The main chain
Morris, R. J., Perrakis, A., & Lamzin, V. S. (2002) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444902005462 · Cited by 201
Dictionary of recurrent domains in protein structures
Holm, L., & Sander, C. (1998) · Proteins: Structure, Function, and Genetics · doi:10.1002/(sici)1097-0134(19981001)33:1<88::aid-prot8>3.0.co;2-h · Cited by 181
Su, S. L., Huang, I.-P., Fair, W. R., Powell, C. T., & Heston, W. D. W. (1995) · PubMed · Cited by 180
The Nagging Question of the Function ofN-Acetylaspartylglutamate
Coyle, J. T. (1997) · Neurobiology of Disease · doi:10.1006/nbdi.1997.0153 · Cited by 173
Bruno, V., Battaglia, G., Copani, A., Giffard, R., Raciti, G., Raffaele, R., Shinozaki, H., & Nicoletti, F. (1995) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1995.tb00712.x · Cited by 147
Heston, W. (1997) · Urology · doi:10.1016/s0090-4295(97)00177-5 · Cited by 130
Slusher, B. S., Robinson, M. B., Tsai, G. E., Simmons, M. L., Richards, S. S., & Coyle, J. T. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)45359-2 · Cited by 129
Self-citationBařinka, C., Rinnová, M., Šácha, P., Rojas, C. J., Majer, P., Slusher, B. S., & Konvalinka, J. (2002) · Journal of Neurochemistry · doi:10.1046/j.0022-3042.2001.00715.x · Cited by 123
Self-citationStreptomyces griseus aminopeptidase: X-ray crystallographic structure at 1.75 Å resolution
Greenblatt, H. M., Almog, O., Maras, B., Spungin‐Bialik, A., Barra, D., Blumberg, S., & Shoham, G. (1997) · Journal of Molecular Biology · doi:10.1006/jmbi.1996.0729 · Cited by 120
Ghadge, G. D., Slusher, B. S., Bodner, A., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1530168100 · Cited by 118
Self-citationSleep disorder related to Parkinson’s disease
Partinen, M. (1997) · Journal of Neurology · doi:10.1007/bf03160564 · Cited by 112
Majer, P., Jackson, P., Delahanty, G., Grella, B. S., Ko, Y.-S., Li, W., Liu, Q., Maclin, K. M., Poláková, J., Shaffer, K. A., et al. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm020515w · Cited by 111
Self-citationBařinka, C., Šácha, P., Sklenář, J., Man, P., Bezouška, K., Slusher, B. S., & Konvalinka, J. (2004) · Protein Science · doi:10.1110/ps.04622104 · Cited by 108
Self-citationGopalakrishnapillai, A., Rajasekaran, S. A., Wang, S., Hankinson, O., Bander, N. H., & Rajasekaran, A. K. (2003) · PubMed · Cited by 97
The extracellular human melanoma inhibitory activity (MIA) protein adopts an SH3 domain‐like fold
Stoll, R., Renner, C., Zweckstetter, M., Brüggert, M., Ambrosius, D., Palme, S., Engh, R. A., Golob, M., Breibach, I., Buettner, R., et al. (2001) · The EMBO Journal · doi:10.1093/emboj/20.3.340 · Cited by 97
Design and Pharmacological Activity of Phosphinic Acid Based NAALADase Inhibitors
Jackson, P., Tays, K. L., Maclin, K. M., Ko, Y.-S., Li, W., Vitharana, D., Tsukamoto, T., Stoermer, D., Lu, X. M., Wozniak, K. M., et al. (2001) · Journal of Medicinal Chemistry · doi:10.1021/jm0001774 · Cited by 95
Self-citationStructure of membrane glutamate carboxypeptidase
Rawlings, N. D., & Barrett, A. J. (1997) · Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology · doi:10.1016/s0167-4838(97)00008-3 · Cited by 93
A Unique Folate Hydrolase, Prostate-Specific Membrane Antigen (PSMA): A Target For Immunotherapy?
Tasch, J. E., Gong, M., Sadelain, M., & Heston, W. D. W. (2001) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.v21.i1-3.160 · Cited by 92
Berger, U. V., Carter, R. E., & Coyle, J. T. (1995) · Neuroscience · doi:10.1016/0306-4522(95)92578-8 · Cited by 90
Design of NAALADase Inhibitors A Novel Neuroprotective Strategy
Jackson, P., & Slusher, B. S. (2001) · Current Medicinal Chemistry · doi:10.2174/0929867013372797 · Cited by 75
Self-citationSekiguchi, M., Okamoto, K., & Sakai, Y. (1989) · Brain Research · doi:10.1016/0006-8993(89)90545-3 · Cited by 74
Puttfarcken, P. S., Handen, J. S., Montgomery, D. T., Coyle, J. T., & Werling, L. L. (1993) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)38400-4 · Cited by 73
Co-catalytic metallopeptidases as pharmaceutical targets
Holz, R. C., Bzymek, K. P., & Swierczek, S. I. (2003) · Current Opinion in Chemical Biology · doi:10.1016/s1367-5931(03)00033-4 · Cited by 71
Site-Directed Mutagenesis of Predicted Active Site Residues in Glutamate Carboxypeptidase II
Speno, H., Luthi‐Carter, R., Macias‐Konstantopoulos, W., Valentine, S. L., Joshi, A. R. T., & Coyle, J. T. (1999) · Molecular Pharmacology · doi:10.1124/mol.55.1.179 · Cited by 57
Lougheed, J. C., Holton, J. M., Alber, T., Bazán, J. F., & Handel, T. M. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.091601698 · Cited by 56
Ghosh, A., & Heston, W. D. W. (2003) · The Prostate · doi:10.1002/pros.10289 · Cited by 51
Chen, S.-R., Wozniak, K. M., Slusher, B. S., & Pan, H. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.300.2.662 · Cited by 50
Self-citationRong, S.-B., Zhang, J., Neale, J. H., Wroblewski, J. T., Wang, S., & Kozikowski, A. P. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm010561g · Cited by 37
Enantiospecificity of Glutamate Carboxypeptidase II Inhibition
Tsukamoto, T., Majer, P., Vitharana, D., Ni, C., Hin, B., Lu, X.-C. M., Thomas, A. G., Wozniak, K. M., Calvin, D. C., Wu, Y., et al. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm049258g · Cited by 27
Self-citationStructural and Functional Stability of the Mature Transferrin Receptor from Human Placenta
Orberger, G., Fuchs, H., Geyer, R., Gessner, R. V., Köttgen, E., & Tauber, R. (2001) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.2000.2177 · Cited by 19
Cited by
Chen, Y., Pullambhatla, M., Foss, C. A., Byun, Y., Nimmagadda, S., Senthamizhchelvan, S., Sgouros, G., Mease, R. C., & Pomper, M. G. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-1357 · Cited by 388
Metadata
- Authors
- Mesters, J. R., Barinka, C., Li, W., Tsukamoto, T., Majer, P., Slusher, B. S., Konvalinka, J., & Hilgenfeld, R.
- Venue
- The EMBO Journal
- Published
- 2006-02-09
- Volume
- 25
- Issue
- 6
- Pages
- 1375-1384
- ISSN
- 0261-4189 (ISSN-L)
- 1460-2075
- OpenAlex
- W2136073863
- Cited by
- 284
- References
- 60
- FWCI
- 9.55
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.